Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | ORBIMED ADVISORS LLC | 631,000 1.220% | -1,080,305 (-63.13%) | Filing History |
| 2022-02-11 10:00 am Purchase | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 4,985,000 9.700% | 2,185,000 (+78.04%) | Filing History |
| 2022-02-10 11:23 am Sale | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | ADAGE CAPITAL PARTNERS GP L.L.C. | 665,000 1.290% | -1,785,000 (-72.86%) | Filing History |
| 2022-02-09 10:04 am Purchase | 2022-02-08 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 3,910,017 7.579% | 1,284,465 (+48.92%) | Filing History |
| 2021-10-28 5:24 pm Purchase | 2021-10-27 | 13G | XENON PHARMACEUTICALS INC XENE | Point72 Asset Management L.P. | 2,641,253 5.100% | 2,641,253 (New Position) | Filing History |